Yamini Natarajan is a Gastroenterology physician affiliated with Kelsey-Seybold Clinic. OpenAlex indexes 55 publications with 3,034 citations (h-index 17).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2727 W Holcombe Blvd
Houston, TX 770251669
Telephone
713-442-0000Provider last certified this registry record 12 Apr 2022.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year20221 payment
- Novo Nordisk IncProgram year20212 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
86.6%Proton pump inhibitor34.7%Omeprazole66%Pantoprazole Sodium27%Esomeprazole Magnesium7%Part D<11 patientsH2 blocker16.3%Famotidine100%Part D≥67 patients+ 10 more classes in this area
Cardiovascular
6.5%Bile Acid Sequestrant3.3%Colestipol Hcl100%Part D<11 patientsBeta blocker1.7%Carvedilol100%Part D<11 patients+ 1 more class in this area
Nervous system
5.2%Phenothiazine2.9%Chlorpromazine Hcl61%Prochlorperazine Maleate39%Part D<11 patientsSNRI2.2%Duloxetine Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Risk of Hepatocellular Carcinoma in Patients with Various HFE Genotypes
Digestive Diseases and Sciences
2022 - Using Natural Language Processing to Automatically Identify Dysplasia in Pathology Reports for Patients With Barrett’s Esophagus
Clinical Gastroenterology and Hepatology
2022 - Clinical Course and Outcomes of Patients with Nonalcoholic Fatty Liver Disease-Related Hepatocellular Cancer (NAFLD-HCC)
Digestive Diseases and Sciences
2022
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”